NCT00570193已完成1 期
Photodynamic and Pharmacologic Treatment of Choroidal Neovascularization (Photodynamic Booster Study)
Mid-Atlantic Retina Consultations, Inc.0 个研究点目标入组 41 人开始时间: 2006年12月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 41
- 主要终点
- Visual change
研究概览
简要总结
The goal of this pilot study is to validate the use of the combination of Lucentis (ranibizumab) and Visudyne (verteporfin) in the treatment of choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) and to explore the use of a volumetric analysis of the CNV lesion to determine disease activity, response to therapy, and as a tool for determining the need for retreatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All previously untreated CNV secondary to MD
排除标准
- 未提供
研究组 & 干预措施
I
Experimental
Combined treatment with verteporfin (Visudyne) and ranibizumab (Lucentis)
干预措施: verteporfin (Visudyne) (Drug)
II
Experimental
Treatment with ranibizumab (Lucentis)
干预措施: ranibizumab (Lucentis) (Drug)
结局指标
主要结局
Visual change
时间窗: 18 months
次要结局
- Frequency of treatment(18 months)
研究者
相似试验
已完成
早期 1 期
Photodynamic Therapy in Treating Patients With Refractory Mycosis FungoidesRefractory Mycosis FungoidesNCT03281811Mayo Clinic11
已完成
不适用
Photobiomodulation and the Intralesional Administration of Corticoid in the Keloid Surgery.KeloidCicatrixNCT04824612University of Nove de Julho4
撤回
2 期
Photodynamic Therapy in the Treatment of Malignant Intracranial TumorsMalignant Intracranial TumorsAnaplastic AstrocytomasAnaplastic OligodendrogliomasAnaplastic EpendymomaGlioblastoma MultiformeNCT00243490National Taiwan University Hospital5
Unknown
不适用
Photodynamic Therapy in Adolescents HalitosisHalitosisNCT02007993University of Nove de Julho130
已完成
1 期
Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic AcidCrohn DiseaseNCT04164849University Hospital, Akershus7